Amplified DNA Testing for Sexually Transmitted Diseases
New Opportunities and New Questions
Arch Pediatr Adolesc Med. 1999;153:111-113.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
WHILE READING about the various new technologies being introduced into the field of pediatrics, I often find myself thinking, "If only the health problems of adolescents were amenable to such advances." At last, that is about to change. The US Food and Drug Administration has approved the first commercial DNA amplification tests for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections and more approvals will follow soon. Work on a polymerase chain reaction test for the detection of Trichomonas vaginalis is also well advanced. I do not think it hyperbole to say that the availability of these new tests will revolutionize our approach to the detection of sexually transmitted diseases (STDs), a major cause of morbidity among adolescents, especially young women. The widespread availability of such tests could not come at a more auspicious time. Adolescents continue to have very high rates of STDs and current research indicates that . . . [Full Text of this Article]
RELATED ARTICLE
Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?
Mary-Ann B. Shafer, Robert H. Pantell, and Julius Schachter
Arch Pediatr Adolesc Med. 1999;153(2):119-125.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Provider willingness to screen all sexually active adolescents for chlamydia
Boekeloo et al.
Sex. Transm. Infect. 2002;78:369-373.
ABSTRACT
| FULL TEXT
Improving Human Immunodeficiency Virus Testing for Adolescents
Joffe
Arch Pediatr Adolesc Med 2001;155:761-762.
FULL TEXT
Urine-Based Screening for STDs
JWatch General 1999;1999:8-8.
FULL TEXT
|
